Insulin aspart: Difference between revisions

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Revision as of 15:49, 5 June 2023 view source Alexander Berchansky (talk \| contribs) 29,637 edits No edit summary ← Older edit		Revision as of 15:50, 5 June 2023 view source Alexander Berchansky (talk \| contribs) 29,637 edits No edit summary Newer edit →
Line 1:		Line 1:
	<StructureSection load='' size='340' side='right' caption='~~Biological Assembly of Insulin aspart,~~ PDB ID [[4gbc]]' scene='96/968809/Cv/2'>		<StructureSection load='' size='340' side='right' caption='PDB ID [[4gbc]]' scene='96/968809/Cv/1'>
	Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart].		Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart].